Hans-Georg Eichler

发表

Topical fundus pulsation measurements in age-related macular degeneration

Oliver Findl, Michael Wolzt, M. Wolzt, 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.

Effect of Information on Reported Adverse Events in a Placebo-Controlled Trial

Martin Aigner, Leopold Schmetterer, Franz König, 2005, Drug safety.

Retinal blood flow and systemic blood pressure in healthy young subjects

Leopold Schmetterer, L. Schmetterer, H. Eichler, 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

Assessing the relative efficacy of new drugs: an emerging opportunity

Sebastian Schneeweiss, S. Schneeweiss, H. Eichler, 2015, Nature Reviews Drug Discovery.

Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension.

Leopold Schmetterer, Wolf Buehl, Clemens Vass, 2004, Investigative ophthalmology & visual science.

A comparison between laser interferometric measurement of fundus pulsation and pneumotonometric measurement of pulsatile ocular blood flow 2. Effects of changes in pCO2 and pO2 and of isoproterenol

Leopold Schmetterer, Oliver Findl, Michael Wolzt, 2000, Eye.

A comparison between laser interferometric measurement of fundus pulsation and pneumotonometric measurement of pulsatile ocular blood flow 1. Baseline considerations

Leopold Schmetterer, Oliver Findl, Michael Wolzt, 2000, Eye.

Recommendations for Good Procedural Practices for Real-World Data Studies of Treatment Effectiveness and/or Comparative Effectiveness Designed to Inform Health Care Decisions: Report of the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making

Harold C. Sox, David Madigan, Wim Goettsch, 2017 .

Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development

Ernst R Berndt, Gigi Hirsch, E. Berndt, 2013, Therapeutic innovation & regulatory science.

New drug approval success rate in Europe in 2009

Tomas Salmonson, Eric Abadie, H. Eichler, 2010, Nature Reviews Drug Discovery.

Transparency and the European Medicines Agency--sharing of clinical trial data.

Guido Rasi, S. Bonini, G. Rasi, 2014, The New England journal of medicine.

The Innovative Medicines Initiative: an engine for regulatory science

Nathalie Seigneuret, Michel Goldman, H. Eichler, 2014, Nature Reviews Drug Discovery.

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

H. Pehamberger, K. Wolff, R. Bryan, 1998, Nature Medicine.

Access to patient-level trial data--a boon to drug developers.

Frank Pétavy, Guido Rasi, Francesco Pignatti, 2013, The New England journal of medicine.

Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative

Wim Goettsch, Sebastian Schneeweiss, C Daniel Mullins, 2020, Pharmacoepidemiology and drug safety.

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

Steven Pearson, Eric Abadie, H. Eichler, 2010, Nature Reviews Drug Discovery.

Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response

Malcolm Rowland, Alasdair Breckenridge, Bruno Flamion, 2011, Nature Reviews Drug Discovery.

Drug Distribution

H. Eichler, Markus Müller, Hans-Georg Eichler, 1998, Clinical pharmacokinetics.

e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers.

Walter E Haefeli, Anna Bucsics, W. Haefeli, 2012, British journal of clinical pharmacology.

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

Alasdair Breckenridge, Bruno Flamion, Francesco Pignatti, 2008, Nature Reviews Drug Discovery.

Improving the contribution of regulatory assessment reports to health technology assessments--a collaboration between the European Medicines Agency and the European network for Health Technology Assessment.

Finn Børlum Kristensen, Wim Goettsch, Mira Pavlovic, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

Karl Broich, Guido Rasi, Ad Schuurman, 2018, Clinical pharmacology and therapeutics.